Aspirin-triggered lipid mediators

Details Aspirin-triggered lipid mediators Aspirin-triggered lipid mediators

C - Chemistry, Metallurgy

07

C

C07C 59/00 (2006.01) C07C 59/58 (2006.01) C07C 69/732 (2006.01)

Patent

CA 2400462

Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment or prevention of inflammation associated with various diseases, including ischemia.

L'invention concerne des médiateurs lipidiques activés par l'aspirine, que l'on utilise pour le traitement ou la prévention de l'inflammation associée à divers maladies, notamment l'ischémie.

Affiliated with

Also associated with

Rating

Aspirin-triggered lipid mediators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aspirin-triggered lipid mediators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aspirin-triggered lipid mediators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1906218